Voyager Therapeutics, Inc.VYGRNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P56
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 1.67% |
| Q3 2025 | 16.45% |
| Q2 2025 | -7.61% |
| Q1 2025 | 10.05% |
| Q4 2024 | -281.32% |
| Q3 2024 | 10.82% |
| Q2 2024 | 10.49% |
| Q1 2024 | -120.09% |
| Q4 2023 | 317.73% |
| Q3 2023 | -16.63% |
| Q2 2023 | -117.90% |
| Q1 2023 | 625.03% |
| Q4 2022 | -234.06% |
| Q3 2022 | 192.34% |
| Q2 2022 | 10.47% |
| Q1 2022 | -473.43% |
| Q4 2021 | 122.71% |
| Q3 2021 | 16.54% |
| Q2 2021 | -39.13% |
| Q1 2021 | -35.93% |
| Q4 2020 | -118.60% |
| Q3 2020 | 1086.19% |
| Q2 2020 | 64.22% |
| Q1 2020 | -92.96% |
| Q4 2019 | 16.21% |
| Q3 2019 | -234.55% |
| Q2 2019 | 141.05% |
| Q1 2019 | -20.58% |
| Q4 2018 | -11.06% |
| Q3 2018 | 20.56% |
| Q2 2018 | -28.18% |
| Q1 2018 | -69.34% |
| Q4 2017 | 49.60% |
| Q3 2017 | -23.68% |
| Q2 2017 | -13.38% |
| Q1 2017 | -13.45% |
| Q4 2016 | -63.12% |
| Q3 2016 | 3.63% |
| Q2 2016 | -29.87% |
| Q1 2016 | 1.30% |